C12N 2310/121
Hammerhead
C12N2310/121 (Hammerhead) appears on 335 US grants and 310 published applications in this corpus.
Search patents in C12N- Granted patents
- 335
- Published applications
- 310
- Assignees
- 149
- Inventors
- 573
- Latest grant
- 7 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 2 | 0 |
| 1993 | 3 | 0 |
| 1994 | 2 | 0 |
| 1995 | 1 | 0 |
| 1996 | 11 | 0 |
| 1997 | 36 | 0 |
| 1998 | 40 | 0 |
| 1999 | 35 | 0 |
| 2000 | 42 | 0 |
| 2001 | 18 | 4 |
| 2002 | 26 | 22 |
| 2003 | 22 | 61 |
| 2004 | 11 | 29 |
| 2005 | 7 | 54 |
| 2006 | 12 | 16 |
| 2007 | 1 | 11 |
| 2008 | 3 | 11 |
| 2009 | 5 | 13 |
| 2010 | 12 | 6 |
| 2011 | 5 | 4 |
| 2012 | 4 | 6 |
| 2013 | 4 | 4 |
| 2014 | 0 | 4 |
| 2015 | 1 | 1 |
| 2016 | 2 | 5 |
| 2017 | 3 | 2 |
| 2018 | 1 | 9 |
| 2019 | 8 | 3 |
| 2020 | 1 | 10 |
| 2021 | 4 | 6 |
| 2022 | 2 | 1 |
| 2023 | 3 | 6 |
| 2024 | 2 | 6 |
| 2025 | 5 | 13 |
| 2026 | 1 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Aptamer and ribozyme equilibrium shifting (ARES) RNA circuits and uses thereof7 Jul 2026US 12,674,171 B2Trustees of Boston University
- RNA cleavage-induced transcript stabilizer and uses thereof25 Nov 2025US 12,480,119 B2Massachusetts Institute of Technology
- Regulation of gene expression via aptamer-mediated control of self-cleaving ribozymes15 Jul 2025US 12,359,199 B2Meiragtx UK II Limited
- Methods and compositions for transducing lymphocytes and regulating the activity thereof25 Mar 2025US 12,258,574 B2Exuma Biotech Corp.
- Compositions and methods to restore paternal UBE3A gene expression in human Angelman syndrome11 Feb 2025US 12,221,609 B2University of Connecticut
- Self-amplifying non-coding rna for targeted gene knockdown13 Aug 2026US 2026/0234618 A1The Regents of the University of California
- Aptazyme-based regulatable gene expression systems18 Jun 2026US 2026/0167959 A1Rejuvenate Bio
- Ribozyme-activated rna constructs and uses thereof30 Apr 2026US 2026/0115275 A1The Regents of the University of California
- Ribozymes4 Dec 2025US 2025/0369036 A1Agency for Science, Technology and Research
- Aptamer and ribozyme equilibrium shifting (ares) rna circuits and uses thereof2 Oct 2025US 2025/0304975 A1Trustees of Boston University
Most cited
By later US patents
- 2'deoxy-2'-alkylnucleotide containing nucleic acid521US 5,627,053 ARibozyme Pharmaceuticals, Inc. · 1997
- Enzymatic nucleic acids containing 5'-and/or 3'-cap structures322US 5,998,203 ARibozyme Pharmaceuticals, Inc. · 1999
- Synthetic catalytic oligonucleotide structures254US 5,334,711 AEuropaisches Laboratorium fur Molekularbiologie (EMBL) · 1994
- Nucleic acid catalysts with endonuclease activity158US 6,127,173 ARibozyme Pharmaceuticals, Inc. · 2000
- RNA polymerase III-based expression of therapeutic RNAs154US 5,902,880 ARibozyme Pharmaceuticals, Inc. · 1999